Ptc Therapeutics (PTCT) Shares Outstanding (Weighted Average) (2012 - 2026)

Ptc Therapeutics' Shares Outstanding (Weighted Average) history runs 15 years deep, the most recent figure standing at $82.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 5.64% year-over-year to $82.5 million; the TTM figure through Mar 2026 stood at $82.5 million (up 5.64% YoY), while the FY2025 annual figure was $79.5 million, up 3.5% from the prior year.
• Shares Outstanding (Weighted Average) was $82.5 million for Q1 2026 at Ptc Therapeutics, up from $79.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $82.5 million in Q1 2026 to a low of $71.2 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $75.8 million across 5 years, with a median of $76.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) grew 1.18% in 2022, then rose 5.64% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $71.7 million in 2022, then gained by 4.34% to $74.8 million in 2023, then advanced by 2.68% to $76.8 million in 2024, then advanced by 3.5% to $79.5 million in 2025, then climbed by 3.76% to $82.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $82.5 million (Q1 2026), $79.5 million (Q4 2025), and $78.6 million (Q3 2025), per Business Quant data.